This report uses routinely collected data in the Defense Medical Surveillance System (DMSS) to characterize the prevalence and burden of fibromyalgia (FM) among members of the active component of the U.S. Armed Forces between 1 Jan 2018 and 31 Dec 2018.
View Article and Find Full Text PDF